Intradrmal Botulinum Toxin A vs. Broadband Light for Post-Acne Redness: What the Latest Trial Shows (2026)

Imagine finally conquering acne, only to be left with a frustrating reminder: persistent facial redness. This is the reality for many, and finding effective solutions can feel like an uphill battle. But a recent study has shed light on a surprising contender in the fight against post-acne redness: Botulinum Toxin A, more commonly known as Botox.

But here's where it gets interesting: Instead of its typical cosmetic use, this study explored the potential of injecting Botox just beneath the skin's surface (intradermally) to combat post-acne erythema. A split-face randomized controlled trial, conducted in China, pitted intradermal Botox against a more established treatment, broadband light therapy.

And this is the part most people miss: The study involved 30 adults, each with one cheek receiving a single Botox injection and the other undergoing three sessions of broadband light treatment over three months. Researchers meticulously tracked various measures like redness intensity, sebum production, skin hydration, and even patient satisfaction.

The results were eye-opening. While both treatments showed promise in reducing redness, Botox emerged as the clear frontrunner. It demonstrated significantly greater reductions in redness, sebum production, and certain colorimetric measurements compared to broadband light, and these improvements were sustained over the three-month period.

Here's the catch: Botox injections were understandably more painful than light therapy. However, patient satisfaction remained comparable, and both treatments proved safe with no major side effects reported.

This study positions intradermal Botox as a potentially game-changing option for those struggling with post-acne redness. A single session could offer noticeable improvements in redness and oily skin, providing a welcome relief for many.

But the story doesn't end here. The study's small size and short follow-up period necessitate larger, longer-term investigations before Botox becomes a mainstream treatment for this condition.

What do you think? Could Botox be the future of post-acne redness treatment, or are the potential drawbacks too significant? Share your thoughts in the comments below!

Reference: Yang L et al. Efficacy and safety of intradermal botulinum toxin A for post-acne erythema: a split-face randomized controlled trial. Front Med. 2025;12:1610125.

Note: This article is licensed under a Creative Commons Attribution-Non Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/).

Intradrmal Botulinum Toxin A vs. Broadband Light for Post-Acne Redness: What the Latest Trial Shows (2026)

References

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Errol Quitzon

Last Updated:

Views: 6763

Rating: 4.9 / 5 (79 voted)

Reviews: 94% of readers found this page helpful

Author information

Name: Errol Quitzon

Birthday: 1993-04-02

Address: 70604 Haley Lane, Port Weldonside, TN 99233-0942

Phone: +9665282866296

Job: Product Retail Agent

Hobby: Computer programming, Horseback riding, Hooping, Dance, Ice skating, Backpacking, Rafting

Introduction: My name is Errol Quitzon, I am a fair, cute, fancy, clean, attractive, sparkling, kind person who loves writing and wants to share my knowledge and understanding with you.